We are definitely looking at it, like we participated in the earlier bond sale by Indonesia. There is going to be a rating upgrade, which is positive.

We're going back to patients who were in our earlier trials. There were about 2,000 who participated and we're encouraged that a high percentage of patients have expressed a desire to enroll in this study.

The last time we bought these bonds, they've been quite a positive exposure.

It'll be a milestone if Sri Lanka can do an international bond.

Let's see what sort of spreads it comes out at.

The worry is the shortage of dollars. The market is watching their reserves position.